Literature DB >> 33026604

TUG1 as a Therapy Target in Pancreatic Cancer.

Haifeng Liang1, Zhaokun Cui2, Qingping Song3.   

Abstract

Entities:  

Year:  2020        PMID： 33026604     DOI： 10.1007/s10620-020-06636-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.

Authors:  Fei Ma; Shou-Hua Wang; Qiang Cai; Long-Yang Jin; Di Zhou; Jun Ding; Zhi-Wei Quan
Journal:  Biomed Pharmacother       Date:  2017-02-06       Impact factor: 6.529

2.  Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.

Authors:  Yunsheng Li; Dan Zheng; Liutong Pan; Yuanting Dai; Shasha Cai; Lijin Zhao; HuiPing Zhu
Journal:  Eur J Pharmacol       Date:  2019-07-13       Impact factor: 4.432

3.  Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.

Authors:  Ke Xu; Lianfeng Zhang
Journal:  Dig Dis Sci       Date:  2019-10-26       Impact factor: 3.199

4.  RETRACTED: Long non-coding RNA TUG1 protects renal tubular epithelial cells against injury induced by lipopolysaccharide via regulating microRNA-223.

Authors:  Yan Xu; Wenyan Deng; Wei Zhang
Journal:  Biomed Pharmacother       Date:  2018-05-25       Impact factor: 6.529

5.  LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a/DKK1/Wnt-β-catenin signalling.

Authors:  Qingxia Fang; Ting Liu; Chenhuan Yu; Xiuli Yang; Yanfei Shao; Jiana Shi; Xiaolan Ye; Xiaochun Zheng; Jieping Yan; Danfeng Xu; Xiaozhou Zou
Journal:  J Cell Mol Med       Date:  2020-02-14       Impact factor: 5.310
  5 in total
  2 in total

1.  Analysis of the subcellular location of FAM230B and its interaction with premature miR-302b in osteosarcoma.

Authors:  Shigao Cheng; Wanchun Wang
Journal:  J Bone Miner Metab       Date:  2022-05-31       Impact factor: 2.626

2.  Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.

Authors:  Qi Liu; Hongyu Zhao; Yu Guo; Kai Zhang; Fengjia Shang; Tongjun Liu
Journal:  J Healthc Eng       Date:  2022-09-05       Impact factor: 3.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.